DRS292228_1.png

Bilypsa Tablet

Therapeutic Class: ANTI DIABETIC
Manufacturer:
Get Quote

Bilypsa Tablet contains Saroglitazar, a dual action peroxisome proliferator-activated receptor (PPAR) inhibitor that aids in the management of high cholesterol, especially triglycerides, as well as blood sugar levels in people with type 2 diabetes. It acts by a unique mechanism in which it reduces the synthesis and secretion of triglycerides (a type of lipid or cholesterol in blood). It also improves insulin sensitivity of the body for better utilization of the existing insulin and hence lowers the blood sugar levels.

Salt Composition: Saroglitazar (4mg)
Strength: Saroglitazar (4mg)
Pack Size: strip of 10 tablets
Uses: Treatment of Noncirrhotic Non-Alcoholic Steatohepatitis|Treatment of Non-alcoholic fatty liver disease|Treatment of Diabetic dyslipidemia (high cholesterol in diabetes)
Table Header
Salt Composition
Saroglitazar (4mg)
Strength
Saroglitazar (4mg)
Pack Size
strip of 10 tablets
Uses
Treatment of Noncirrhotic Non-Alcoholic Steatohepatitis|Treatment of Non-alcoholic fatty liver disease|Treatment of Diabetic dyslipidemia (high cholesterol in diabetes)
DISCLAIMER
N Chimanlal Enterprises (www.pilcare.com) is WHO GDP and ISO 9001 2015 Certified Pharmaceutical Wholesaler/ Supplier/ Exporters/ Importer from India. Product is supplied for Tenders/ Emergency imports/ Unlicensed, Specials, Orphan drug/ Name patient line/ RLD supplies/ Reference listed drugs/ Comparator Drug/ Bio-Similar/ Innovator samples For Clinical trials. Product names, logos, brands and other trademarks featured or referred to are the property of their respective Trademark Holders. The information provided here is for Informational purposes only.

Product information is meant for


WholesalersSuppliersExportersDoctorsMOH Tender SuppliesHospitalsBrandCROsComparator SuppliesGenericCooperate SourcingIndividual PatientsIndian Institutional Buyers
Recently Viewed
Categories